Discover
YDES
YD Bio Ltd
2.31
1 x 2.31
1 x 2.49
bid
ask
+
0.02
0.87%
1 @ 04:09 AM
2.16 -0.15 (6.49%)
| Ytd | -81.05% | |
| 1y | -82.71% |
2.21
day range
2.97
2.14
52 week range
25.00
| Open | 2.54 | Prev Close | 2.29 | Low | 2.21 | High | 2.97 | Mkt Cap | 163.62M |
| Vol | 131.61K | Avg Vol | 33.11K | EPS | -0.12 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.16 | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.00 | 200-d Avg | 9.74 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Cerity Partners LLC | 32.41K | 429.06K | 0.05% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 20.86K | 276.21K | 0.03% |